antolrx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | ANTOLRX | Antigen Tolerance |
| Description | Revolutionizing the Treatment of Autoimmune Our Vision Science Pipeline Team News Careers Select Page Revolutionizing the Treatment of Autoimmune Diseases MORE ABOUT OUR NOVEL TECHNOLOGY Our Vision |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 66.94.40.4 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
antolrx.com Valuation
|
US$2,187,824
Last updated: 2023-05-11 23:50:09
antolrx.com has Semrush global rank of 4,837,823. antolrx.com has an estimated worth of US$ 2,187,824, based on its estimated Ads revenue. antolrx.com receives approximately 252,442 unique visitors each day. Its web server is located in United States, with IP address 66.94.40.4. According to SiteAdvisor, antolrx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,187,824 |
| Daily Ads Revenue | US$2,020 |
| Monthly Ads Revenue | US$60,586 |
| Yearly Ads Revenue | US$727,031 |
| Daily Unique Visitors | 16,830 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| antolrx.com. | A | 14400 | IP: 66.94.40.4 |
| antolrx.com. | NS | 21600 | NS Record: whdns01.ttlc.com. |
| antolrx.com. | NS | 21600 | NS Record: whdns02.ttlc.com. |
| antolrx.com. | MX | 600 | MX Record: 0 antolrx-com.mail.protection.outlook.com. |
| antolrx.com. | TXT | 14400 | TXT Record: v=spf1 mx a ip4:66.96.128.0/18 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-11 23:50:09
| Our Vision Science Pipeline Team News Careers Select Page Revolutionizing the Treatment of Autoimmune Diseases MORE ABOUT OUR NOVEL TECHNOLOGY Our Vision Addressing significant unmet needs in the field of autoimmunity through the development of novel patented therapies for treatment of disease. Read More Pipeline AnTolRx’s vision is to build a platform that selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases. Our Pipeline Latest News Tolerogenic nanoparticles suppress central nervous system inflammation Dec 15, 2020 Kenison, J.E. et al. PNAS doi: 10.1073/pnas.2016451117. PMID: 33239445 (2020). read more CONTACT AnTolRx info@antolrx.com 617-902-0601 Home Our Vision Science Pipeline News Careers Contact © 2023 ANTOLRX | Website by |
antolrx.com Whois Information
Domain Name: ANTOLRX.COM Registry Domain ID: 1878399609_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2021-09-30T13:01:54Z Creation Date: 2014-09-30T20:37:23Z Registry Expiry Date: 2023-09-30T20:37:23Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: WHDNS01.TTLC.COM Name Server: WHDNS02.TTLC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-19T07:30:24Z <<< |